Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
1 result(s) for "Rüegg, Stephan, Prof"
Sort by:
Anti-GABA A receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia
Repeated MRIs, from days 5 to 12 after admission, showed progression of the multiple cortico-subcortical lesions ( figure); the EEG showed right-hemispheric temporo-parietal focal slowing independent of the worsening of the patient's condition. UFischer reports research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, Medtronic, Stryker, Penumbra, Rapid medical, Phenox, and Boehringer Ingelheim; consulting fees from Medtronic, Stryker, CSL Behring (fees paid to institution); has membership in a data safety monitoring board for the TITAN trial, IN EXTREMIS trial, LATE-MT trial, Rapid Puls Trial; has membership in the Clinical Event Committee of the COATING Trial (Phenox) and membership in the advisory board for CLS Behring, Acthera, Alexion/Portola, Boehringer Ingelheim (all fees paid to institution); is president of the Swiss Neurological Society. Acknowledgments We thank the patient for his consent and all health-care professionals who were involved in his treatment at the Department of Neurology; Department of Radiology; Department of Intensive Care; Department of Medicine; Department of Anaesthesiology; Institute of Pathology; Department of Neurosurgery; and the Emergency Department of the University Hospital Basel, Switzerland; the REHAB Clinic for Neurorehabilitation, Basel, Switzerland; and the Laboratory Krone, Bad Salzuflen, Germany.